Autoreactive B cells and epigenetics

Clinical Reviews in Allergy and Immunology

Volumn 39, Issue 1, 2010, Pages 85-94

  Renaudineau, Yves ^a,c,d   Garaud, Soizic ^a   Le Dantec, Christelle ^a   Alonso Ramirez, Ruby ^a,b   Daridon, Capucine ^a,c   Youinou, Pierre ^a,c  

^a Universite de Brest   (France)

^b CENTER OF MOLECULAR IMMUNOLOGY   (Cuba)

^c CHU MORVAN   (France)

^d BREST UNIVERSITY HOSPITAL   (France)

Author keywords

Autoimmunity; B cells; Epigenetic; Systemic lupus erythematosus

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; B LYMPHOCYTE INDUCED MATURATION PROTEIN 1; B LYMPHOCYTE RECEPTOR; DNA METHYLTRANSFERASE 1; DNA METHYLTRANSFERASE 3A; DNA METHYLTRANSFERASE 3B; GAMMA INTERFERON; HISTONE ACETYLTRANSFERASE; HISTONE DEACETYLASE; HISTONE H1; HISTONE H2A; HISTONE H2B; HISTONE H3; HISTONE H4; HYDRALAZINE; INTERLEUKIN 4; INTERLEUKIN 6; MESSENGER RNA; METHYL CPG BINDING PROTEIN; METHYL CPG BINDING PROTEIN 2; MICRORNA; PROTEIN ARGININE DEIMINASE; PROTEIN MBD1; PROTEIN MBD3; PROTEIN MBD4; PROTEIN PADI4; RAF PROTEIN; RAG1 PROTEIN; RAG2 PROTEIN; RNA INDUCED SILENCING COMPLEX; TRICHOSTATIN A; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ACETYLATION; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CD4+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL MATURATION; CPG ISLAND; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DERMATOMYOSITIS; DNA METHYLATION; DRUG ACTIVITY; ENDOGENOUS RETROVIRUS; EPIGENETICS; GENE EXPRESSION; HISTONE CODE; HUMAN; NONHUMAN; PLASMA CELL; PRE B LYMPHOCYTE; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION; REVIEW; RHEUMATOID ARTHRITIS; RISK FACTOR; SIGNAL TRANSDUCTION; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; UBIQUITINATION;

ANIMALS; ANTIGEN PRESENTATION; AUTOANTIBODIES; AUTOANTIGENS; AUTOIMMUNE DISEASES; B-LYMPHOCYTES; CYTOKINES; DNA METHYLATION; EPIGENESIS, GENETIC; HISTONES; HUMANS; PROTEIN PROCESSING, POST-TRANSLATIONAL;

EID: 77954088611     PISSN: 10800549     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12016-009-8174-6     Document Type: Review

References (87)

1. G Hom RR Graham B Modrek, et al. 2008 Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX N Engl J Med 358 900 909 10.1056/NEJMoa0707865 18204098 (Pubitemid 351397089)
2. MF Fraga E Ballestar MF Paz, et al. 2005 Epigenetic differences arise during the lifetime of monozygotic twins Proc Natl Acad Sci U S A 102 10604 10609 10.1073/pnas.0500398102 16009939 (Pubitemid 41061601)
3. S Garaud C Le Dantec S Jousse-Joulin, et al. 2009 IL-6 modulates CD5 expression in B cells from patients with lupus by regulating DNA methylation J Immunol 182 5623 5632 10.4049/jimmunol.0802412 19380809
4. E Balada J Ordi-Ros M Vilardell-Tarrés 2007 DNA methylation and systemic lupus erythematosus Ann N Y Acad Sci 1108 127 136 10.1196/annals.1422. 015 17893979 (Pubitemid 47528726)
5. B Richardson L Scheinbart J Strahler L Gross S Hanash M Johnson 1990 Evidence for impaired T cell DNA methylation in systemic lupus erythematosus and rheumatoid arthritis Arthritis Rheum 33 1665 1673 10.1002/art.1780331109 2242063
6. M Neidhart J Rethage S Kuchen, et al. 2000 Retrotransposable L1 elements expressed in rheumatoid arthritis synovial tissue: association with genomic DNA hypomethylation and influence on gene expression Arthritis Rheum 43 2634 2647 10.1002/1529-0131(200012)43:12<2634::AID-ANR3>3.0.CO;2-1 11145021 (Pubitemid 32001729)
7. YH Lee YH Rho SJ Choi JD Ji GG Song 2007 PADI4 polymorphisms and rheumatoid arthritis susceptibility: a meta-analysis Rheumatol Int 27 827 833 10.1007/s00296-007-0320-y 17265154 (Pubitemid 46906647)
8. R Webb JD Wren M Jeffries, et al. 2009 Variants within MECP2, a key transcription regulator, are associated with increased susceptibility to lupus and differential gene expression in patients with systemic lupus erythematosus Arthritis Rheum 60 1076 1084 10.1002/art.24360 19333917
9. AH Sawalha R Webb S Han, et al. 2008 Common variants within MECP2 confer risk of systemic lupus erythematosus PLoS ONE 3 e1727 10.1371/journal.pone. 0001727 18320046 (Pubitemid 351903230)
10. CZ Chen L Li HF Lodish DP Bartel 2004 MicroRNAs modulate hematopoietic lineage differentiation Science 303 83 86 10.1126/science.1091903 14657504 (Pubitemid 38055775)
11. MA Lindsay 2008 MicroRNAs and the immune response Trends Immunol 29 343 351 10.1016/j.it.2008.04.004 18515182
12. KM Pauley M Satoh AL Chan MR Bubb WH Reeves EK Chan 2008 Upregulated miR-146a expression in peripheral blood mononuclear cells from rheumatoid arthritis patients Arthritis Res Ther 10 R101 10.1186/ar2344 18759964 (Pubitemid 351150061)
13. T Nakasa S Miyaki A Okubo, et al. 2008 Expression of microRNA-146 in rheumatoid arthritis synovial tissue Arthritis Rheum 58 1284 1292 10.1002/art.23429 18438844 (Pubitemid 351705917)
14. Y Tang X Luo H Cui, et al. 2009 MicroRNA-146A contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins Arthritis Rheum 60 1065 1075 10.1002/art.24436 19333922
15. Y Dai YS Huang M Tang, et al. 2007 Microarray analysis of microRNA expression in peripheral blood cells of systemic lupus erythematosus patients Lupus 16 939 946 10.1177/0961203307084158 18042587
16. Y Dai W Sui H Lan Q Yan H Huang Y Huang 2008 Comprehensive analysis of microRNA expression patterns in renal biopsies of lupus nephritis patients Rheumatol Int 10.1007/s00296-008-0758-6
17. M Danbara K Kameyama M Higashihara Y Takagaki 2002 DNA methylation dominates transcriptional silencing of Pax5 in terminally differentiated B cell lines Mol Immunol 38 1161 1166 10.1016/S0161-5890(02)00003-2 12044782 (Pubitemid 34607248)
18. L Amaravadi MJ Klemsz 1999 DNA methylation and chromatin structure regulate PU.1 expression DNA Cell Biol 18 875 884 10.1089/104454999314737 10619599 (Pubitemid 30013440)
19. H Maier J Colbert D Fitzsimmons DR Clark J Hagman 2003 Activation of the early B-cell-specific mb-1 (Ig-alpha) gene by Pax-5 is dependent on an unmethylated Ets binding site Mol Cell Biol 23 1946 1960 10.1128/MCB.23.6.1946- 1960.2003 12612069 (Pubitemid 36278808)
20. K Walter C Bonifer H Tagoh 2008 Stem cell-specific epigenetic priming and B cell-specific transcriptional activation at the mouse Cd19 locus Blood 112 1673 1682 10.1182/blood-2008-02-142786 18552207
21. J Schwab H Illges 2001 Silencing of CD21 expression in synovial lymphocytes is independent of methylation of the CD21 promoter CpG island Rheumatol Int 20 133 137 10.1007/s002960000090 11411956 (Pubitemid 32449109)
22. D O'Carroll I Mecklenbrauker PP Das, et al. 2007 A Slicer-independent role for Argonaute 2 in hematopoiesis and the microRNA pathway Genes Dev 21 1999 2004 10.1101/gad.1565607 17626790 (Pubitemid 47267286)
23. SB Koralov SA Muljo GR Galler, et al. 2008 Dicer ablation affects antibody diversity and cell survival in the B lymphocyte lineage Cell 132 860 874 10.1016/j.cell.2008.02.020 18329371 (Pubitemid 351312808)
24. D Baltimore MP Boldin RM O'Connell DS Rao KD Taganov 2008 MicroRNAs: new regulators of immune cell development and function Nat Immunol 9 839 845 10.1038/ni.f.209 18645592 (Pubitemid 352038302)
25. TH Thai DP Calado S Casola, et al. 2007 Regulation of the germinal center response by microRNA-155 Science 316 604 608 10.1126/science.1141229 17463289 (Pubitemid 46683147)
26. A Rodriguez E Vigorito S Clare, et al. 2007 Requirement of bic/microRNA-155 for normal immune function Science 316 608 611 10.1126/science.1139253 17463290 (Pubitemid 46683148)
27. C Xiao DP Calado G Galler, et al. 2007 MiR-150 controls B cell differentiation by targeting the transcription factor c-Myb Cell 131 146 159 10.1016/j.cell.2007.07.021 17923094 (Pubitemid 47498525)
28. J Baxter S Sauer A Peters, et al. 2004 Histone hypomethylation is an indicator of epigenetic plasticity in quiescent lymphocytes EMBO J 23 4462 4472 10.1038/sj.emboj.7600414 15510223 (Pubitemid 39601971)
29. PO Estève HG Chin A Smallwood, et al. 2006 Direct interaction between DNMT1 and G9a coordinates DNA and histone methylation during replication Genes Dev 20 3089 3103 10.1101/gad.1463706 17085482 (Pubitemid 44790625)
30. LR Thomas H Miyashita RM Cobb, et al. 2008 Functional analysis of histone methyltransferase g9a in B and T lymphocytes J Immunol 181 485 493 18566414
31. M Ehrlich K Jackson C Weemaes 2006 Immunodeficiency, centromeric region instability, facial anomalies syndrome (ICF) Orphanet J Rare Dis 1 2 10.1186/1750-1172-1-2 16722602
32. CE Blanco-Betancourt A Moncla M Milili, et al. 2004 Defective B-cell-negative selection and terminal differentiation in the ICF syndrome Blood 103 2683 2690 10.1182/blood-2003-08-2632 14645008 (Pubitemid 38393025)
33. B Jin Q Tao J Peng, et al. 2008 DNA methyltransferase 3B (DNMT3B) mutations in ICF syndrome lead to altered epigenetic modifications and aberrant expression of genes regulating development, neurogenesis and immune function Hum Mol Genet 17 690 709 10.1093/hmg/ddm341 18029387 (Pubitemid 351292258)
34. M Ehrlich C Sanchez C Shao, et al. 2008 ICF, an immunodeficiency syndrome: DNA methyltransferase 3B involvement, chromosome anomalies, and gene dysregulation Autoimmunity 41 253 271 10.1080/08916930802024202 18432406 (Pubitemid 351593856)
35. SC Lee A Bottaro RA Insel 2003 Activation of terminal B cell differentiation by inhibition of histone deacetylation Mol Immunol 39 923 932 10.1016/S0161-5890(03)00029-4 12695118 (Pubitemid 36419604)
36. J Yu C Angelin-Duclos J Greenwood J Liao K Calame 2000 Transcriptional repression by blimp-1 (PRDI-BF1) involves recruitment of histone deacetylase Mol Cell Biol 20 2592 2603 10.1128/MCB.20.7.2592-2603.2000 10713181 (Pubitemid 30152065)
37. K Ancelin UC Lange P Hajkova, et al. 2006 Blimp1 associates with Prmt5 and directs histone arginine methylation in mouse germ cells Nat Cell Biol 8 623 630 10.1038/ncb1413 16699504 (Pubitemid 43827356)
38. I Gyory J Wu G Fejér E Seto KL Wright 2004 PRDI-BF1 recruits the histone H3 methyltransferase G9a in transcriptional silencing Nat Immunol 5 299 308 10.1038/ni1046 14985713 (Pubitemid 38332127)
39. CR Xu AJ Feeney 2009 The epigenetic profile of Ig genes is dynamically regulated during B cell differentiation and is modulated by pre-B cell receptor signaling J Immunol 182 1362 1369 10.4049/jimmunol.0900123 19155482
40. CR Espinoza AJ Feeney 2007 Chromatin accessibility and epigenetic modifications differ between frequently and infrequently rearranging VH genes Mol Immunol 44 2675 2685 10.1016/j.molimm.2006.12.002 17218014 (Pubitemid 46240315)
41. H Nakase Y Takahama Y Akamatsu 2003 Effect of CpG methylation on RAG1/RAG2 reactivity: implications of direct and indirect mechanisms for controlling V(D)J cleavage EMBO 4 774 780 10.1038/sj.embor.embor904 (Pubitemid 37063185)
42. M Larijani D Frieder TM Sonbuchner, et al. 2005 Methylation protects cytidines from AID-mediated deamination Mol Immunol 42 599 604 10.1016/j.molimm.2004.09.007 15607819 (Pubitemid 39655938)
43. VH Odegard ST Kim SM Anderson MJ Shlomchik DG Schatz 2005 Histone modifications associated with somatic hypermutation Immunity 23 101 110 10.1016/j.immuni.2005.05.007 16039583 (Pubitemid 41019661)
44. P Youinou TE Taher JO Pers RA Mageed Y Renaudineau 2009 B-lymphocyte cytokines and rheumatic autoimmune disease Arthritis Rheum 60 1873 1880 10.1002/art.24665 19565509
45. DP Harris L Haynes PC Sayles, et al. 2000 Reciprocal regulation of polarized cytokine production by effector B and T cells Nat Immunol 1 475 482 10.1038/82717 11101868
46. Y Pang Y Norihisa D Benjamin RR Kantor HA Young 1992 Interferon-gamma gene expression in human B-cell lines: induction by interleukin-2, protein kinase C activators, and possible effect of hypomethylation on gene regulation Blood 80 724 732 1322203
47. PC Janson P Marits M Thörn R Ohlsson O Winqvist 2008 CpG methylation of the IFNG gene as a mechanism to induce immunosuppression [correction of immunosupression] in tumor-infiltrating lymphocytes J Immunol 181 2878 2886 18684979
48. I Yamamoto T Matsunaga K Sakata Y Nakamura S Doi F Hanmyou 1996 Histone hyperacetylation plays a role in augmentation of IL-4-induced IgE production in LPS-stimulated murine B-lymphocytes by sodium butyrate J Biochem 119 1056 1061 8827437
49. A Cannat M Seligmann 1968 Induction by isoniazid and hydrallazine of antinuclear factors in mice Clin Exp Immunol 3 99 105 5300375
50. JH Ten Veen TE Feltkamp 1972 Studies on drug induced lupus erythematosus in mice. I. Drug induced antinuclear antibodies (ANA) Clin Exp Immunol 11 265 276 4557182
51. LM Dubroff RJ Reid Jr 1980 Hydralazine-pyrimidine interactions may explain hydralazine-induced lupus erythematosus Sciences 208 404 406
52. BH Lee S Yegnasubramanian X Lin WG Nelson 2005 Procainamide is a specific inhibitor of DNA methyltransferase 1 J Biol Chem 280 40749 40756 10.1074/jbc.M505593200 16230360 (Pubitemid 41780565)
53. C Deng Q Lu Z Zhang, et al. 2003 Hydralazine may induce autoimmunity by inhibiting extracellular signal-regulated kinase pathway signaling Arthritis Rheum 48 746 756 10.1002/art.10833 12632429 (Pubitemid 36302012)
54. J Quddus KJ Johnson J Gavalchin, et al. 1993 Treating activated CD4+ T cells with either of two distinct DNA methyltransferase inhibitors, 5-azacytidine or procainamide, is sufficient to cause a lupus-like disease in syngeneic mice J Clin Invest 92 38 53 10.1172/JCI116576 7686923
55. RL Yung J Quddus CE Chrisp KJ Johnson BC Richardson 1995 Mechanism of drug-induced lupus. I. Cloned Th2 cells modified with DNA methylation inhibitors in vitro cause autoimmunity in vivo J Immunol 154 3025 3035 7533191
56. L Mazari M Ouarzane M Zouali 2007 Subversion of B lymphocyte tolerance by hydralazine, a potential mechanism for drug-induced lupus Proc Natl Acad Sci U S A 104 6317 6322 10.1073/pnas.0610434104 17404230 (Pubitemid 47186092)
57. VW Bauer TL Squire ME Lowe MT Andrews 2001 Expression of a chimeric retroviral-lipase mRNA confers enhanced lipolysis in a hibernating mammal Am J Physiol Regul Integr Comp Physiol 281 R1186 R1192 11557627
58. J Wu T Zhou J He JD Mountz 1993 Autoimmune disease in mice due to integration of an endogenous retrovirus in an apoptosis gene J Exp Med 178 461 468 10.1084/jem.178.2.461 7688023
59. Y Qian C Santiago M Borrero TF Tedder SH Clarke 2001 Lupus-specific antiribonucleoprotein B cell tolerance in nonautoimmune mice is maintained by differentiation to B-1 and governed by B cell receptor signaling thresholds J Immunol 166 2412 2419 11160300
60. KL Hippen LE Tze TW Behrens 2000 CD5 maintains tolerance in anergic B cells J Exp Med 191 883 890 10.1084/jem.191.5.883 10704468
61. C Jamin G Magadur A Lamour, et al. 1992 Cell-free CD5 in patients with rheumatic diseases Immunol Lett 31 79 83 10.1016/0165-2478(92)90014-F 1372282
62. X Lu RC Axtell JF Collawn A Gibson LB Justement C Raman 2002 AP2 adaptor complex-dependent internalization of CD5: differential regulation in T and B cells J Immunol 168 5612 5620 12023358
63. Y Renaudineau S Hillion A Saraux RA Mageed P Youinou 2005 An alternative exon 1 of the CD5 gene regulates CD5 expression in human B lymphocytes Blood 106 2781 2789 10.1182/blood-2005-02-0597 15998834 (Pubitemid 41510754)
64. S Garaud C Le Dantec C Berthou PM Lydyard P Youinou Y Renaudineau 2008 Selection of the alternative exon 1 from the cd5 gene down-regulates membrane level of the protein in B lymphocytes J Immunol 181 2010 2018 18641338
65. Y Renaudineau S Vallet C Le Dantec S Hillion A Saraux P Youinou 2005 Characterization of the human CD5 endogenous retrovirus-E in B lymphocytes Genes Immun 6 663 671 16107871 (Pubitemid 41741711)
66. R Pullmann Jr E Bonilla PE Phillips FA Middleton A Perl 2008 Haplotypes of the HRES-1 endogenous retrovirus are associated with development and disease manifestations of systemic lupus erythematosus Arthritis Rheum 58 532 540 10.1002/art.23161 18240231 (Pubitemid 351294887)
67. A Perl E Colombo H Dai, et al. 1995 Antibody reactivity to the HRES-1 endogenous retroviral element identifies a subset of patients with systemic lupus erythematosus and overlap syndromes. Correlation with antinuclear antibodies and HLA class II alleles Arthritis Rheum 38 1660 1671 10.1002/art.1780381119 7488288
68. G Nagy J Ward DD Mosser, et al. 2006 Regulation of CD4 expression via recycling by HRES-1/RAB4 controls susceptibility to HIV infection J Biol Chem 281 34574 34591 10.1074/jbc.M606301200 16935861 (Pubitemid 46036664)
69. DR Fernandez T Telarico E Bonilla, et al. 2009 Activation of mammalian target of rapamycin controls the loss of TCRzeta in lupus T cells through HRES-1/Rab4-regulated lysosomal degradation J Immunol 182 2063 2073 10.4049/jimmunol.0803600 19201859
70. MK Adelman JJ Marchalonis 2002 Endogenous retroviruses in systemic lupus erythematosus: candidate lupus viruses Clin Immunol 102 107 116 10.1006/clim.2001.5153 11846452 (Pubitemid 34171509)
71. AE Chambers S Banerjee T Chaplin, et al. 2003 Histone acetylation-mediated regulation of genes in leukaemic cells Eur J Cancer 39 1165 1175 10.1016/S0959-8049(03)00072-8 12736119 (Pubitemid 36555877)
72. MD Zabel JJ Weis JH Weis 1999 Lymphoid transcription of the murine CD21 gene is positively regulated by histone acetylation J Immunol 163 2697 2703 10453011
73. JS Seo NY Cho HR Kim, et al. 2008 Cell cycle arrest and lytic induction of EBV-transformed B lymphoblastoid cells by a histone deacetylase inhibitor, Trichostatin A Oncol Rep 19 93 98 18097580
74. N Mishra CM Reilly DR Brown P Ruiz GS Gilkeson 2003 Histone deacetylase inhibitors modulate renal disease in the MRL-lpr/lpr mouse J Clin Invest 111 539 552 12588892
75. C Xiao L Srinivasan DP Calado, et al. 2008 Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes Nat Immunol 9 405 414 10.1038/ni1575 18327259 (Pubitemid 351405110)
76. BL Park LH Kim HD Shin YW Park WS Uhm SC Bae 2004 Association analyses of DNA methyltransferase-1 (DNMT1) polymorphisms with systemic lupus erythematosus J Hum Genet 49 642 646 10.1007/s10038-004-0192-x 15375672 (Pubitemid 40385254)
77. G Gorelik JY Fang A Wu AH Sawalha B Richardson 2007 Impaired T cell protein kinase C delta activation decreases ERK pathway signaling in idiopathic and hydralazine-induced lupus J Immunol 179 5553 5563 17911642
78. A Miyamoto K Nakayama H Imaki, et al. 2002 Increased proliferation of B cells and auto-immunity in mice lacking protein kinase Cdelta Nature 416 865 869 10.1038/416865a 11976687 (Pubitemid 34453744)
79. EC Jury DA Isenberg C Mauri MR Ehrenstein 2006 Atorvastatin restores Lck expression and lipid raft-associated signaling in T cells from patients with systemic lupus erythematosus J Immunol 177 7416 7422 17082661
80. K Oelke Q Lu D Richardson, et al. 2004 Overexpression of CD70 and overstimulation of IgG synthesis by lupus T cells and T cells treated with DNA methylation inhibitors Arthritis Rheum 50 1850 1860 10.1002/art.20255 15188362 (Pubitemid 38725098)
81. H Nagumo K Agematsu 1998 Synergistic augmentative effect of interleukin-10 and CD27/CD70 interactions on B-cell immunoglobulin synthesis Immunology 94 388 394 10.1046/j.1365-2567.1998.00521.x 9767422 (Pubitemid 28318605)
82. B Liang DB Gardner DE Griswold PJ Bugelski XY Song 2006 Anti-interleukin-6 monoclonal antibody inhibits autoimmune responses in a murine model of systemic lupus erythematosus Immunology 119 296 305 10.1111/j.1365-2567.2006.02433.x 17067309 (Pubitemid 44571047)
83. LP Tang CH Cho WM Hui, et al. 2006 An inverse correlation between Interleukin-6 and select gene promoter methylation in patients with gastric cancer Digestion 74 85 90 10.1159/000097623 17139167 (Pubitemid 46192732)
84. S Hillion S Garaud V Devauchelle, et al. 2007 Interleukin-6 is responsible for aberrant B-cell receptor-mediated regulation of RAG expression in systemic lupus erythematosus Immunology 122 371 380 10.1111/j.1365-2567.2007. 02649.x 17608810 (Pubitemid 47556474)
85. N Hu X Qiu Y Luo, et al. 2008 Abnormal histone modification patterns in lupus CD4+ T cells J Rheumatol 35 804 810 18398941
86. W Lei Y Luo K Yan, et al. 2009 Abnormal DNA methylation in CD4+ T cells from patients with systemic lupus erythematosus, systemic sclerosis, and dermatomyositis Scand J Rheumatol 14 1 6
87. LC Huber M Brock H Hemmatazad, et al. 2007 Histone deacetylase/acetylase activity in total synovial tissue derived from rheumatoid arthritis and osteoarthritis patients Arthritis Rheum 56 1087 1093 10.1002/art.22512 17393417 (Pubitemid 46608633)